BENIGN CLINICAL PICTURE AFTER INGESTION OF 780 MILLIGRAMS OF ARIPIPRAZOLE AND 1050 MILLIGRAMS OF AMITRIPTYLINE
Sir, Intentional psychotropic overdose is a common cause of fatal complications in psychiatric patients. In addition to the much discussed antidepressant overdoses, antipsychotic Figure 1 ]. Subsequently a gastric lavage was performed and he was given injection Pancef (1 ampoule). After 8 hours of the procedure, he was discharged and was referred back to our institute. Retrieval of his Þ le in our institute revealed that he was Among the antidepressants, Amitryptiline has been one of those most commonly associated with death when used in overdose. [3] Symptoms usually appear within 4 hours of an overdose and recovery can be expected within 24 hours provided the poisoning is not severe. Common clinical features are its anticholinergic, and CNS symptoms. The most frequent Þ ndings on the ECG are prolongation of the PR and QT intervals. [4, 10] In our patient, in spite of the apparently high dose intake of this much feared agent, only the transiently elevated blood pressure and heart rate were observed. Such high dose intake in the range 13.6/kg-17.7mg/ kg was associated with severe complications in children as per a recent study. [5] A speculative proposition could be that the long-term use (>4 yrs) of Amitryptiline created tolerance for the dose. This hypothetical situation is worth consideration as there are reports where daily doses as high as 800 mg/day have been tolerated when used for a long time for abuse. [6, 7] Aripiprazole acts by exhibiting high-affinity partial agonist activity at D2-dopamine receptors. [8] In a few years after its FDA approval, it has earned the reputation of having a benign side effect proÞ le. Its overdose has been occasionally reported. Our literature search revealed 8 cases of Aripiprazole overdose till date, most of them being in children. Clinical presentation ranged from no symptoms to extreme lethargy, central nervous system (CNS) depression, intentional tremor, and Parkinsonian gait. [2] In adults fewer cases have been reported. The maximum dose reported till date is 330 mg, where the effects were limited to mild sedation. [9] Our patient apparently tolerated more than double this dose (780 mg). The excessive sedation, dizziness and instability of gait for a few hours could have been due to this overdose, however these can be equally attributed to Amytriptiline. This adds to the literature of this new molecule in terms of its safety in high doses.
SEVERE DELIRIUM FOLLOWING SINGLE DOSE OF TRAMADOL
Sir, Given the volume of use of analgesic preparations with approved indications for acute pain, a number of drug interactions including less well-known and potentially clinically significant drug-drug interactions are increasingly being reported. [1] A 32-yearold male on treatment for cysticercosis was receiving Tab. albendazole, phenytoin, steroids and ranitidine. Meanwhile, the patient developed allergic rhinitis, fever, body and joint pain. His general and systemic examination was normal. He was started on cetrizine for allergy and tramadol for body and joint pain. There was no concomitant use of antidepressants. The patient continued to receive Tab. albendazole and oral steroid without any change in dosage. After 6 hours he developed violent behavior and delirium. There were no myoclonic twitches or muscular rigidity. On examination he had tachycardia and excessive sweating. Pupils were bilateral 3 mm in size? and reacting to light. Bowel and bladder functions were normal. Blood investigations showed raised erythrocyte sedimentation rate, blood urea and serum creatinine were normal. Facilities for estimation were not available. The abnormal behavior could be controlled with haloperidol and both the drugs (tramadol and cetrizine) were discontinued. The Naranjo score [2] for adverse drug reaction was 9. There was no history of any signiÞ cant illness prior to cysticercosis and he was not an alcoholic. He responded well and recovered completely. Although tramadol may represent a well-established, safe therapy for pain, [3] [4] [5] abuse and dependence on tramadol as well as tramadol-related deaths have been increasingly reported, either when the drug is ingested alone or taken in combination with other potentially interactive drugs. [5] [6] [7] Mild and transient central nervous system stimulation during therapy with tramadol has been reported in 7% of patients in clinical trials. [7] The debilitating reaction following a single oral dose of tramadol may include ataxia, dilation of the pupils, numbness, tremulousness, and dysphoria lasting for hours and disappearing after discontinuation of the therapy. [7] Rarely may it lead to fluctuating confusion and cognitive deficits (reversible after discontinuation of the drug). [8] The exact mechanism of the adverse response is not known; however, based on phenotyping results, it has been suspected that it may be related to high concentrations of the active O-desmethyl metabolite of tramadol. [7] 
